한국지질동맥경화학회 학술대회

Statin therapy Strategies for Newly Diagnosed Dyslipidemia Patients in Clinical Practice

Low-dose atorvastatin: addressing an unmet clinical need

The role of low-dose fenofibrate in the management of dyslipidemia

A new oral LDL-C lowering agent with proven CV benefit: bempedoic acid

Integrated lipid management across the CKM spectrum: from evidence to practice

TBD (Lecture Title)

TBD (Lecture Title)

The emerging role of ApoB and triglyceride-rich lipoproteins

Beyond LDL-C: targeting inflammation and lipoprotein(a) to address residual cardiovascular risk in Asia

Cardiometabolic residual risk in Asia: diabetes, metabolic dysfunction, and vascular aging

Oxidized phospholipids on lipoprotein(a): a key driver of atherothrombosis?

Does lipoprotein(a) promote thrombosis? evidence from genetics and population studies

Epidemiology and cardiovascular events: what have we learned?

Dyslipidemia across ethnicities in Malaysia: who is at risk, and who is being left behind?

Genetic architecture of dyslipidemia and cardiovascular risk in East Asians: from monogenic variants to polygenic risk

Epidemiological trends of dyslipidemia in Korea and their implications for Asian populations

Beyond LDL-C lowering: strategies for maximizing residual ASCVD risk reduction

Perspective on residual risk, inflammation, and atherosclerosis: from epidemiology to precision prevention

TBD (Lecture Title)

New paradigm of initial therapy for hypertension: which patients benefit from amoprel?

Combination treatment in hypertension: why is losartan-based therapy effective?

TBD (Lecture Title)

Residual cardiovascular risk in hypertension despite optimal BP control

Lipid management in hypertensive patients

Obesity, insulin resistance, and hypertension-related vascular injury

Impact of lipid-lowering therapy on plaque stabilization and regression

Coronary microvascular dysfunction after PCI

Discordance between CAC and coronary stenosis

Hypertriglyceridemia and remnant cholesterol in diabetes

Arterial stiffness and vascular aging in diabetes

Coronary artery calcium and subclinical atherosclerosis in diabetes

Cardiologist perspective: implementing novel cardiometabolic therapies in CVD

Nephrologist’s perspective: kidney protection strategies to improve cardio-kidney outcomes

Endocrinologist perspective: optimizing combination therapy in complex CKM patients

AI-CVD: opportunistic testing of coronary calcium and beyond

From physics to physiology: computational hemodynamics and coronary flow modeling in atherosclerosis

Application of AI to coronary angiography

AI-based retinomics: cardiovascular risk prediction using retinal imaging

Lipid management in primary prevention: who, when, and how aggressive?

Life’s essential 8: concept, evidence, and clinical impact

Advancing cardiovascular management through vaccination

Diabetic dyslipidemia: targeting residual risk beyond LDL-C lowering

Subclinical thyroid dysfunction: when should we treat for lipid control?

Atherogenic dyslipidemia in women: PCOS, menopause, and cardiovascular risk

Brain GPCR targets and circuits controlling food intake

Understanding gene-diet interactions in cardiometabolic health

Interaction effects of genetic variants and dietary intake on the development of metabolic syndrome

ESC/EAS dyslipidemia guidelines: recent updates and evidence base

Korean perspectives on dyslipidemia guidelines: recent update and challenges

Translating guidelines into practice

Non-inflammatory function of dendritic cell in the regulation of obesity-associated heart failure

Hepatic lipotoxicity and fibrotic remodeling in metabolic liver disease

From lipidomics to systems biology: decoding metabolic networks

Atherosclerosis and atherosclerotic cardiovascular disease in Asia: the knowledge gap for the determinants

Air pollution and cardiovascular disease

Microplastics and cardiovascular health: current epidemiological evidence and challenges

Climate change and cardiometabolic disease